Skip to main content

Frontotemporal Lobar Degeneration (FTLD)

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Biosensics
BiosensicsMA - Newton
1 program
Digital Measurements of Motor and Voice Functions in FTDN/A1 trial
Active Trials
NCT07333898Not Yet Recruiting20Est. Dec 2028

Trial Timeline

Clinical trial activity over time

2026
2027
2028
BiosensicsDigital Measurements of Motor and Voice Functions in FTD

Clinical Trials (1)

Total enrollment: 20 patients across 1 trials

NCT07333898BiosensicsDigital Measurements of Motor and Voice Functions in FTD

Digital Measurements of Motor and Voice Functions in FTD

Start: Aug 2026Est. completion: Dec 202820 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.